HHM Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.6K Buy
266
+21
+9% +$2.77K ﹤0.01% 444
2026
Q1
$34.1K Sell
245
-67
-21% -$9.38K ﹤0.01% 418
2025
Q4
$38.3K Hold
312
﹤0.01% 397
2025
Q3
$34.6K Sell
312
-39
-11% -$4.43K ﹤0.01% 428
2025
Q2
$38.9K Hold
351
﹤0.01% 411
2025
Q1
$39.3K Buy
351
+67
+24% +$6.91K 0.01% 399
2024
Q4
$26.2K Buy
284
+154
+118% +$13.9K ﹤0.01% 457
2024
Q3
$10.9K Hold
130
﹤0.01% 546
2024
Q2
$8.92K Hold
130
﹤0.01% 561
2024
Q1
$9.52K Hold
130
﹤0.01% 530
2023
Q4
$10.5K Hold
130
﹤0.01% 503
2023
Q3
$9.74K Hold
130
﹤0.01% 511
2023
Q2
$10K Hold
130
﹤0.01% 530
2023
Q1
$10.8K Hold
130
﹤0.01% 513
2022
Q4
$11.2K Hold
130
﹤0.01% 437
2022
Q3
$8K Sell
130
-1,394
-91% -$87.9K ﹤0.01% 466
2022
Q2
$94K Hold
1,524
0.02% 198
2022
Q1
$91K Hold
1,524
0.02% 230
2021
Q4
$111K Hold
1,524
0.03% 207
2021
Q3
$106K Sell
1,524
-17
-1% -$1.19K 0.03% 197
2021
Q2
$106K Sell
1,541
-200
-11% -$13.4K 0.03% 196
2021
Q1
$113K Hold
1,741
0.04% 172
2020
Q4
$101K Sell
1,741
-693
-28% -$41.8K 0.03% 170
2020
Q3
$154K Buy
2,434
+9
+0.4% +$624 0.06% 104
2020
Q2
$187K Buy
2,425
+200
+9% +$15.3K 0.08% 87
2020
Q1
$166K Buy
+2,225
New +$154K 0.08% 85

Other funds holding GILD

HHM Wealth Advisors's GILD Position: Q2 2026 in Review

HHM Wealth Advisors increased its Gilead Sciences (GILD) stake by 8.6% in Q2 2026, buying an estimated $2.77K and bringing the position to 266 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #444.

HHM Wealth Advisors first reported a position in GILD in Q1 2020 and has held it in 26 quarters since. The position peaked at $187K in Q2 2020. 759 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • HHM Wealth Advisors held 266 shares of Gilead Sciences worth $33.6K as of Q2 2026.
  • HHM Wealth Advisors bought 21 Gilead Sciences shares in Q2 2026, an estimated $2.77K.
  • Gilead Sciences made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #444 holding.
  • HHM Wealth Advisors first reported a position in Gilead Sciences in Q1 2020 and has held it in 26 quarters since.
  • HHM Wealth Advisors's Gilead Sciences position peaked at $187K in Q2 2020.
  • 759 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.